Medical big data: promise and challenges

다국어 초록 (Multilingual Abstract)

The concept of big data, commonly characterized by volume, variety, velocity, and veracity, goes far beyond the data type and includes the aspects of data analysis, such as hypothesis-generating, rather than hypothesis-testing. Big data focuses on temporal stability of the association, rather than on causal relationship and underlying probability distribution assumptions are frequently not required. Medical big data as material to be analyzed has various features that are not only distinct from big data of other disciplines, but also distinct from traditional clinical epidemiology. Big data technology has many areas of application in healthcare, such as predictive modeling and clinical decision support, disease or safety surveillance, public health, and research. Big data analytics frequently exploits analytic methods developed in data mining, including classification, clustering, and regression. Medical big data analyses are complicated by many technical issues, such as missing values, curse of dimensionality, and bias control, and share the inherent limitations of observation study, namely the inability to test causality resulting from residual confounding and reverse causation. Recently, propensity score analysis and instrumental variable analysis have been introduced to overcome these limitations, and they have accomplished a great deal. Many challenges, such as the absence of evidence of practical benefits of big data, methodological issues including legal and ethical issues, and clinical integration and utility issues, must be overcome to realize the promise of medical big data as the fuel of a continuous learning healthcare system that will improve patient outcome and reduce waste in areas including nephrology.

참고문헌 (Reference)

• 1 Iwashyna TJ, "What’s so different about big data?. A primer for clinicians trained to think epidemiologically" 11 : 1130-1135, 2014
• 2 Meltzer AC, "What big data can and cannot tell us about emergency department quality for urolithiasis" 22 : 481-482, 2015
• 3 Dinov ID, "Volume and value of big healthcare data" 4 : 3-, 2016
• 4 Murdoch TB, "The inevitable application of big data to health care" 309 : 1351-1352, 2013
• 5 Tai V, "Results of observational studies:analysis of findings from the Nurses’ Health Study" 9 : e11040-, 2014
• 6 Concato J, "Randomized, controlled trials, observational studies, and the hierarchy of research designs" 342 : 1887-1892, 2000
• 7 DeRouen TA, "Promises and pitfalls in the use of “Big Data”for clinical research" 94 (94): 107S-109S, 2015
• 8 Bellazzi R, "Predictive data mining in clinical medicine: current issues and guidelines" 77 : 81-97, 2008
• 9 Laborde-Castérot H, "Performing both propensity score and instrumental variable analyses in observational studies often leads to discrepant results: a systematic review" 68 : 1232-1240, 2015
• 10 Tanaka S, "Methodological issues in observational studies and non-randomized controlled trials in oncology in the era of big data" 45 : 323-327, 2015
• 11 Dinov ID, "Methodological challenges and analytic opportunities for modeling and interpreting Big Healthcare Data" 5 : 12-, 2016
• 12 Boef AG, "Mendelian randomization studies: a review of the approaches used and the quality of reporting" 44 : 496-511, 2015
• 13 Khoury MJ, "Medicine. Big data meets public health" 346 : 1054-1055, 2014
• 14 Lavecchia A, "Machine-learning approaches in drug discovery:methods and applications" 20 : 318-331, 2015
• 15 Deo RC, "Machine learning in medicine" 132 : 1920-1930, 2015
• 16 Sinha A, "Large datasets in biomedicine:a discussion of salient analytic issues" 16 : 759-767, 2009
• 17 Scruggs SB, "Harnessing the heart of big data" 116 : 1115-1119, 2015
• 18 Wong WK, "Handling missing data issues in clinical trials for rheumatic diseases" 32 : 1-9, 2011
• 19 Alyass A, "From big data analysis to personalized medicine for all: challenges and opportunities" 8 : 33-, 2015
• 20 Li L, "Dimension reduction for high-dimensional data" 620 : 417-434, 2010
• 21 Roski J, "Creating value in health care through big data: opportunities and policy implications" 33 : 1115-1122, 2014
• 22 Iavindrasana J, "Clinical data mining: a review" 121-133, 2009
• 23 Slobogean GP, "Bigger data, bigger problems" 29 (29): S43-S46, 2015
• 24 Ketchersid T, "Big data in nephrology: friend or foe?" 36 : 160-164, 2013
• 25 Binder H, "Big data in medical science--a biostatistical view" 112 : 137-142, 2015
• 26 Wang W, "Big data and clinicians: a review on the state of the science" 2 : e1-, 2014
• 27 Bellazzi R, "Big data and biomedical informatics: a challenging opportunity" 9 : 8-13, 2014
• 28 Rumsfeld JS, "Big data analytics to improve cardiovascular care: promise and challenges" 13 : 350-359, 2016
• 29 Saeys Y, "A review of feature selection techniques in bioinformatics" 23 : 2507-2517, 2007
• 30 Benson K, "A comparison of observational studies and randomized, controlled trials" 342 : 1878-1886, 2000